Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients

Behavioral and Brain Functions

Volumn 6, Issue , 2010, Pages

  Nemoda, Zsofia ^a   Lyons Ruth, Karlen ^b   Szekely, Anna ^c   Bertha, Eszter ^b   Faludi, Gabor ^a   Sasvari Szekely, Maria ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b CAMBRIDGE HOSPITAL   (United States)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; DRD4 PROTEIN, HUMAN; SLC6A3 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BORDERLINE STATE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; FEMALE; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; COMPARATIVE STUDY; GENETIC VARIABILITY; GENETICS; INTERNATIONAL COOPERATION; MENTAL DISEASE; PHYSIOLOGY; PROMOTER REGION; PSYCHIATRIC DEPARTMENT;

ADOLESCENT; BORDERLINE PERSONALITY DISORDER; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENETIC VARIATION; HUMANS; INTERNATIONALITY; MALE; MENTAL DISORDERS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PSYCHIATRIC DEPARTMENT, HOSPITAL; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; RISK FACTORS; YOUNG ADULT;

EID: 76949083115     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-6-4     Document Type: Article

References (68)

1. Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M. Borderline personality disorder. Lancet 2004, 364:453-461. 10.1016/S0140-6736(04)16770-6, 15288745.
2. Nigg JT, Goldsmith HH. Genetics of personality disorders: perspectives from personality and psychopathology research. Psychol Bull 1994, 115:346-380. 10.1037/0033-2909.115.3.346, 8016285.
3. Torgersen S, Lygren S, Oien PA, Skre I, Onstad S, Edvardsen J, Tambs K, Kringlen E. A twin study of personality disorders. Compr Psychiatry 2000, 41:416-425. 10.1053/comp.2000.16560, 11086146.
4. Distel MA, Trull TJ, Derom CA, Thiery EW, Grimmer MA, Martin NG, Willemsen G, Boomsma DI. Heritability of borderline personality disorder features is similar across three countries. Psychol Med 2008, 38:1219-1229. 10.1017/S0033291707002024, 17988414.
5. Oquendo MA, Mann JJ. The biology of impulsivity and suicidality. Psychiatr Clin North Am 2000, 23:11-25. 10.1016/S0193-953X(05)70140-4, 10729928.
6. Friedel RO. Dopamine dysfunction in borderline personality disorder: A hypothesis. Neuropsychopharmacology 2004, 29:1029-1039. 10.1038/sj.npp.1300424, 15039763.
7. Joyce PR, McHugh PC, McKenzie JM, Sullivan PF, Mulder RT, Luty SE, Carter JD, Frampton CM, Robert Cloninger C, Miller AM, Kennedy MA. A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients. Psychol Med 2006, 36:807-813. 10.1017/S0033291706007288, 16623961.
8. Tadić A, Victor A, Başkaya O, von Cube R, Hoch J, Kouti I, Anicker NJ, Höppner W, Lieb K, Dahmen N. Interaction between gene variants of the serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT) in borderline personality disorder. Am J Med Genet B 2009, 150:487-495.
9. Oak JN, Oldenhof J, Van Tol HH. The dopamine D(4) receptor: one decade of research. Eur J Pharmacol 2000, 405:303-327. 10.1016/S0014-2999(00)00562-8, 11033337.
10. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1313-1323. 10.1016/j.biopsych.2004.11.024, 15950004.
11. Munafò MR, Yalcin B, Willis-Owen SA, Flint J. Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data. Biol Psychiatry 2008, 63:197-206. 10.1016/j.biopsych.2007.04.006, 17574217.
12. Posner MI, Rothbart MK, Vizueta N, Thomas KM, Levy KN, Fossella J, Silbersweig D, Stern E, Clarkin J, Kernberg O. An approach to the psychobiology of personality disorders. Dev Psychopathol 2003, 15:1093-1106. 10.1017/S0954579403000506, 14984139.
13. Lyons-Ruth K, Holmes BM, Sasvari-Szekely M, Ronai Z, Nemoda Z, Pauls D. Serotonin transporter polymorphism and borderline or antisocial traits among low-income young adults. Psychiatr Genet 2007, 17:339-343. 10.1097/YPG.0b013e3281ac237e, 2149895, 18075474.
14. Cohen P, Chen H, Gordon K, Johnson J, Brook J, Kasen S. Socioeconomic background and the developmental course of schizotypal and borderline personality disorder symptoms. Dev Psychopathol 2008, 20(2):633-50. 10.1017/S095457940800031X, 18423098.
15. Page A, Taylor R, Hall W, Carter G. Mental disorders and socioeconomic status: impact on population risk of attempted suicide in Australia. Suicide Life Threat Behav 2009, 39:471-81. 10.1521/suli.2009.39.5.471, 19929148.
16. Widiger TA, Weissman MM. Epidemiology of borderline personality disorder. Hosp Community Psychiatry 1991, 42:1015-1021.
17. Moran P. The epidemiology of antisocial personality disorder. Soc Psychiatry Psychiatr Epidemiol 1999, 34:231-242. 10.1007/s001270050138, 10396164.
18. Neville MJ, Johnstone EC, Walton RT. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 2004, 23:540-545. 10.1002/humu.20039, 15146457.
19. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997, 7(6):479-484. 10.1097/00008571-199712000-00006, 9429233.
20. Pohjalainen T, Rinne JO, Någren K, Lehikoinen P, Anttila K, Syvälahti EK, Hietala J. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998, 3:256-260. 10.1038/sj.mp.4000350, 9672901.
21. Jönsson EG, Nöthen MM, Grünhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 1999, 4:290-296. 10.1038/sj.mp.4000532, 10395223.
22. Ritchie T, Noble EP. Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 2003, 28:73-82. 10.1023/A:1021648128758, 12587665.
23. Laruelle M, Gelernter J, Innis RB. D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. Mol Psychiatry 1998, 3:261-265. 10.1038/sj.mp.4000343, 9672902.
24. Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B 2003, 116:103-125.
25. Eisenberg DT, Mackillop J, Modi M, Beauchemin J, Dang D, Lisman SA, Lum JK, Wilson DS. Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study. Behav Brain Funct 2007, 3:2. 10.1186/1744-9081-3-2, 1781951, 17214892.
26. White MJ, Morris CP, Lawford BR, Young RM. Behavioral phenotypes of impulsivity related to the ANKK1 gene are independent of an acute stressor. Behav Brain Funct 2008, 4:54. 10.1186/1744-9081-4-54, 2607297, 19025655.
27. Schoots O, Van Tol HH. The human dopamine D4 receptor repeat sequences modulate expression. Pharmacogenomics J 2003, 3:343-348. 10.1038/sj.tpj.6500208, 14581929.
28. Eisenberg DT, Campbell B, Mackillop J, Lum JK, Wilson DS. Season of birth and dopamine receptor gene associations with impulsivity, sensation seeking and reproductive behaviors. PLoS One 2007, 2:e1216. 10.1371/journal.pone.0001216, 2075470, 18030347.
29. Beaver KM, Wright JP, DeLisi M, Walsh A, Vaughn MG, Boisvert D, Vaske J. A gene × gene interaction between DRD2 and DRD4 is associated with conduct disorder and antisocial behavior in males. Behav Brain Funct 2007, 3:30. 10.1186/1744-9081-3-30, 1913922, 17587443.
30. Congdon E, Lesch KP, Canli T. Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity. Am J Med Genet B 2008, 147:27-32.
31. Bakermans-Kranenburg MJ, van Ijzendoorn MH. Gene-environment interaction of the dopamine D4 receptor (DRD4) and observed maternal insensitivity predicting externalizing behavior in preschoolers. Dev Psychobiol 2006, 48:406-409. 10.1002/dev.20152, 16770765.
32. Bakermans-Kranenburg MJ, Van IJzendoorn MH, Pijlman FT, Mesman J, Juffer F. Experimental evidence for differential susceptibility: dopamine D4 receptor polymorphism (DRD4 VNTR) moderates intervention effects on toddlers' externalizing behavior in a randomized controlled trial. Dev Psychol 2008, 44:293-300. 10.1037/0012-1649.44.1.293, 18194028.
33. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. User's guide for the structured clinical interview for DSM-IV Axis II personality disorders [SCID-II]. 1997, Washington, DC: American Psychiatric Press.
34. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders - Clinical version (SCID-CV). 1997, Washington D.C.: American Psychiatric Press.
35. Straus MA, Hamby SL, Boney-McCoy S, Sugarman DB. The revised Conflict Tactics Scales (CTS2): Development and preliminary psychometric data. Journal of Family Issues 1996, 17:283-316.
36. Norris FH. Epidemiology of trauma: frequency and impact of different potentially traumatic events on different demographic groups. J Consult Clin Psychol 1992, 60:409-418. 10.1037/0022-006X.60.3.409, 1619095.
37. Dutra L, Bureau JF, Holmes B, Lyubchik A, Lyons-Ruth K. Quality of early care and childhood trauma: a prospective study of developmental pathways to dissociation. J Nerv Ment Dis 2009, 197:383-390. 10.1097/NMD.0b013e3181a653b7, 2697443, 19525736.
38. Hejjas K, Szekely A, Domotor E, Halmai Z, Balogh G, Schilling B, Sarosi A, Faludi G, Sasvari-Szekely M, Nemoda Z. Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach. Am J Med Genet B 2009, 150:295-299.
39. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 1994, Washington, DC: American Psychiatric Press, 4, American Psychiatric Association.
40. Ekselius L, Lindström E, von Knorring L, Bodlund O, Kullgren G. SCID II interviews and the SCID Screen questionnaire as diagnostic tools for personality disorders in DSM-III-R. Acta Psychiatr Scand 1994, 90:120-123. 10.1111/j.1600-0447.1994.tb01566.x, 7976457.
41. Grandy DK, Zhang Y, Civelli O. PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet 1993, 2:2197. 10.1093/hmg/2.12.2197-a, 7906592.
42. Castiglione CM, Deinard AS, Speed WC, Sirugo G, Rosenbaum HC, Zhang Y, Grandy DK, Grigorenko EL, Bonne-Tamir B, Pakstis AJ, Kidd JR, Kidd KK. Evolution of haplotypes at the DRD2 locus. Am J Hum Genet 1995, 57:1445-56. 1801414, 8533775.
43. Kidd KK, Pakstis AJ, Castiglione CM, Kidd JR, Speed WC, Goldman D, Knowler WC, Lu RB, Bonne-Tamir B. DRD2 haplotypes containing the TaqI A1 allele: implications for alcoholism research. Alcohol Clin Exp Res 1996, 20:697-705. 10.1111/j.1530-0277.1996.tb01674.x, 8800387.
44. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992, 14:1104-1106. 10.1016/S0888-7543(05)80138-7, 1478653.
45. Ronai Z, Guttman A, Nemoda Z, Staub M, Kalasz H, Sasvari-Szekely M. Rapid and sensitive genotyping of dopamine D4 receptor tandem repeats by automated ultrathin-layer gel electrophoresis. Electrophoresis 2000, 21(10):2058-2061. 10.1002/1522-2683(20000601)21:10<2058::AID-ELPS2058>3.0.CO;2-1, 10879966.
46. Szantai E, Kiraly O, Nemoda Z, Kereszturi E, Csapo Z, Sasvari-Szekely M, Gervai J, Ronai Z. Linkage analysis and molecular haplotyping of the dopamine D4 receptor gene promoter region. Psychiatr Genet 2005, 15:259-270. 10.1097/00041444-200512000-00008, 16314756.
47. Tarnok Z, Ronai Z, Gervai J, Kereszturi E, Gadoros J, Sasvari-Szekely M, Nemoda Z. Dopaminergic candidate genes in Tourette syndrome: Association between tic severity and 3' UTR polymorphism of the dopamine transporter gene. Am J Med Genet 2007, 144:900-905.
48. Christensen K. Calculation of Chi-square test for deviation from Hardy-Weinberg equilibrium. , http://www.husdyr.kvl.dk/htm/kc/popgen/genetik/applets/kitest.htm
49. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125:279-284. 10.1016/S0166-4328(01)00297-2, 11682119.
50. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Human Heredity 2008, 66:87-98. 10.1159/000119108, 2386559, 18382088.
51. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-5. 10.1093/bioinformatics/bth457, 15297300.
52. Young LJ, Wang Z. The neurobiology of pair bonding. Nat Neurosci 2004, 7:1048-1054. 10.1038/nn1327, 15452576.
53. Curtis JT, Liu Y, Aragona BJ, Wang Z. Dopamine and monogamy. Brain Res 2006, 1126:76-90. 10.1016/j.brainres.2006.07.126, 16950234.
54. Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 2009, 14:60-70. 10.1038/sj.mp.4002086, 2668513, 17893706.
55. Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997, 6:577-582. 10.1093/hmg/6.4.577, 9097961.
56. Mill J, Asherson P, Craig I, D'Souza UM. Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1). BMC Genet 2005, 6:3. 10.1186/1471-2156-6-3, 549191, 15683546.
57. Wonodi I, Hong LE, Stine OC, Mitchell BD, Elliott A, Roberts RC, Conley RR, McMahon RP, Thaker GK. Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophrenia. Am J Med Genet 2009, 150:282-289.
58. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000, 22:133-139. 10.1016/S0893-133X(99)00099-8, 10649826.
59. van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M, Baldwin RM, Innis RB, Gelernter J. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 2005, 46:745-751.
60. Giessen EM, de Win MM, Tanck MW, Brink W, Baas F, Booij J. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 2009, 50:45-52. 10.2967/jnumed.108.053652, 19091889.
61. White MJ, Lawford BR, Morris CP, Young RM. Interaction between DRD2 C957T polymorphism and an acute psychosocial stressor on reward-related behavioral impulsivity. Behav Genet 2009, 39:285-95. 10.1007/s10519-008-9255-7, 19148742.
62. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003, 12:205-16. 10.1093/hmg/ddg055, 12554675.
63. Hirvonen M, Laakso A, Någren K, Rinne JO, Pohjalainen T, Hietala J. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 2004, 9:1060-1. Erratum in: Mol Psychiatry 2005, 10:889, 10.1038/sj.mp.4001561, 15278099.
64. Hirvonen MM, Laakso A, Någren K, Rinne JO, Pohjalainen T, Hietala J. C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 2009, 63:907-12. 10.1002/syn.20672, 19582781.
65. Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J. Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum Mol Genet 2007, 16:2844-2853. 10.1093/hmg/ddm240, 17761687.
66. Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, Inohara N, Li MD. Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacology 2009, 34:319-330. 10.1038/npp.2008.37, 18354387.
67. Young RM, Lawford BR, Nutting A, Noble EP. Advances in molecular genetics and the prevention and treatment of substance misuse: Implications of association studies of the A1 allele of the D2 dopamine receptor gene. Addict Behav 2004, 29:1275-1294. 10.1016/j.addbeh.2004.06.012, 15345265.
68. Smith L, Watson M, Gates S, Ball D, Foxcroft D. Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review. Am J Epidemiol 2008, 167:125-138. 10.1093/aje/kwm281, 17989061.